Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

Gelijkaardige items

• Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
  door: Mukhtyar, C, et al.
  Gepubliceerd in: (2006)
• Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
  door: Mukhtyar, C, et al.
  Gepubliceerd in: (2008)
• Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
  door: Saket Jha, et al.
  Gepubliceerd in: (2019-01-01)
• Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
  door: Zhi-Ying Li, et al.
  Gepubliceerd in: (2020-08-01)
• Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
  door: Moog P, et al.
  Gepubliceerd in: (2015-11-01)